Core Insights - C3 AI, an enterprise artificial intelligence software provider, is considering a potential sale following the resignation of founder Thomas Siebel as CEO due to health concerns [1] Company Developments - The company is exploring various options, including a potential sale, after the leadership change [1]

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. by Berger Montague PC on behalf of investors who acquired shares during the specified class period, alleging misleading statements regarding the company's growth and CEO's health [1][3]. Company Overview - C3.ai, headquartered in Redwood City, California, is recognized as a leading provider of enterprise artificial intelligence software [2]. Legal Action Details - The lawsuit claims that C3.ai and certain executives made materially false and misleading statements or failed to disclose adverse information about the company's growth prospects and the impact of the CEO's health on operations [3]. - Investors who purchased C3.ai securities during the class period have until October 21, 2025, to seek appointment as lead plaintiff representatives [2]. Financial Impact - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its full-year revenue guidance, attributing this to leadership reorganization and the CEO's health [3]. - Following this announcement, C3.ai's stock price fell from $22.13 per share on August 8 to $16.47 per share on August 11, marking a decline of over 25% [3].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. by Berger Montague on behalf of investors who acquired shares during the specified class period, alleging misleading statements regarding the company's growth and CEO's health [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased C3.ai shares from February 26, 2025, to August 8, 2025 [1][2]. - Investors have until October 21, 2025, to seek appointment as lead plaintiff [2]. Group 2: Allegations Against C3.ai - The complaint claims that C3.ai and its executives made materially false statements and failed to disclose adverse information about the company's growth prospects and the CEO's health [3]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its full-year revenue guidance, attributing this to leadership reorganization and the CEO's health [3]. Group 3: Stock Price Impact - Following the announcement on August 8, 2025, C3.ai's stock price fell from $22.13 per share to $16.47 per share by August 11, representing a decline of over 25% [3].